Pamplona Capital Management nears deal to buy Parexel: WSJ

(Reuters) - Private equity firm Pamplona Capital Management is nearing a deal to buy contract drug research firm Parexel International Corp for $4.6 billion, the Wall Street Journal reported on Tuesday.